Coca-Cola's Revenue Soars as Weight-Loss Drug Concerns Diminish
TL;DR Summary
Coca-Cola has downplayed concerns about its involvement in a weight-loss drug as it raises its revenue forecast. The company faced criticism after it was revealed that it had funded a study promoting the benefits of exercise over diet in weight loss. However, Coca-Cola maintains that it supports a balanced diet and exercise, and that it is committed to transparency and responsible marketing. The company has also raised its revenue forecast for the year, citing strong demand for its products.
- Coca-Cola plays down weight-loss drug fears as it raises revenue forecast Financial Times
- Coca-Cola beats earnings estimates, raises outlook as volume grows despite price hikes CNBC
- Wait for Coke to Go Flat Before Buying More RealMoney
- Coca-Cola CEO: Marketing acts as a 'motor' to drive financial results Marketing Week
- Coca-Cola (NYSE:KO) Has More To Do To Multiply In Value Going Forward Yahoo Finance
Reading Insights
Total Reads
0
Unique Readers
11
Time Saved
0 min
vs 1 min read
Condensed
32%
117 → 79 words
Want the full story? Read the original article
Read on Financial Times